The blood-brain barrier in multiple sclerosis

被引:7
|
作者
McQuaid, S [1 ]
Kirk, J [1 ]
机构
[1] Queens Univ Belfast, Sch Med, Pathol Dept Neuropathol, Belfast BT7 1NN, Antrim, North Ireland
来源
Drug Transport(ers) and the Diseased Brain | 2005年 / 1277卷
关键词
multiple sclerosis; blood-brain barrier; tight junctions; immunofluorescence; pathology;
D O I
10.1016/j.ics.2005.02.026
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Perivascular inflammiation and blood-brain barrier (BBB) leakage marks a key stage in the development of the typical scattered demyelinated lesions in multiple sclerosis (MS). Immunocytochemistry and confocal laser microscopy were used to analyse the status of inter-endothelial BBB tight junctions (TJ) in MS lesional and normal-appearing white matter (NAWM) and in control white matter. The results revealed TJ abnormalities which, though most common in active lesions (42% of vessels affected), were also present in inactive lesions (23%), in NIS NAWN (13%) and in neurological control white matter (8%). The observed baseline for normal controls was 3.7%. Vessels of all sizes were affected equally and TJ abnormality was associated with serum protein leakage (extravascular fibrinogen immunoreactivity). Tight junctional abnormalities seen included discontinuities in fluorescent signal, redistribution of signal from membranes to cytoplasm and apparent separation of junctions. These findings taken with the results of previous studies, which showed cytoplasmic alterations in MS microvessels consistent with increased transcellular transport, point to a partial loss of BBB phenotype and to possible mechanisms of leakage. The resultant increased vascular permeability in many parts of the lesional and non-lesional white matter is likely to impair homeostasis and may affect both disease progression and drug delivery. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 50 条
  • [1] Role of the Blood-Brain Barrier in Multiple Sclerosis
    Gabriel Ortiz, Genaro
    Paul Pacheco-Moises, Fermin
    Angel Macias-Islas, Miguel
    Javier Flores-Alvarado, Luis
    Mireles-Ramirez, Mario A.
    Daniela Gonzalez-Renovato, Erika
    Elizabeth Hernandez-Navarro, Vanessa
    Lizeth Sanchez-Lopez, Angelica
    Alejandro Alatorre-Jimenez, Moises
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (08) : 687 - 697
  • [2] The blood-brain barrier, chemokines and multiple sclerosis
    Holman, David W.
    Klein, Robyn S.
    Ransohoff, Richard M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (02): : 220 - 230
  • [3] Blood-brain barrier characteristics in multiple sclerosis
    Kooij, Gijs
    van Horssen, Jack
    van der Pol, Susanne
    Dijkstra, Christine
    de Vries, Elga
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 145 - 145
  • [4] Blood-brain barrier disruption in multiple sclerosis
    Minagar, A
    Alexander, JS
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (06) : 540 - 549
  • [5] The blood-brain barrier in cortical multiple sclerosis lesions
    van Horssen, Jack
    Brink, Bianca P.
    de Vries, Helga E.
    van der Valk, Paul
    Bo, Lars
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (04): : 321 - 328
  • [6] Biomarkers of blood-brain barrier in the progression of multiple sclerosis
    Valado, A.
    Proenca, T.
    Sargento-Freitas, J.
    Batista, S.
    Sousa, L.
    Oliveira, C. R.
    Baldeiras, I.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 262 - 263
  • [7] POSTMORTEM EVALUATION OF BLOOD-BRAIN BARRIER IN MULTIPLE SCLEROSIS
    TOURTELLOTTE, WW
    PARKER, JA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1968, 27 (01): : 159 - +
  • [8] Identification of Blood-Brain Barrier Disrupting Factors in Multiple Sclerosis
    Kho, Dan
    Johnson, Rebecca H.
    O'Carroll, Simon J.
    Pereira, Jennifer
    Graham, E. Scott
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP6 - NP6
  • [9] The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
    Kamphuis, Wouter W.
    Troletti, Claudio Derada
    Reijerkerk, Aric
    Romero, Ignacio A.
    de Vries, Helga E.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (02) : 157 - 167